Ophthalmology Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Ophthalmology Case Reports 44 7897 074717

Case Report - Ophthalmology Case Reports (2026) Volume 10, Issue 2

Corneal diseases: Keratitis, therapy, and beyond.

Olivia M. Bennett*

Department of Ophthalmology, Southern Medical University, Australia

*Corresponding Author:
Olivia M. Bennett
Department of Ophthalmology
Southern Medical University, Australia.
E-mail: olivia.bennett@example.com

Received : 15-Jan-2026, Manuscript No. OCR-2-114; Editor assigned : 19-Jan-2026, PreQC No. OCR-2-114(PQ); Reviewed : 06-Feb-2026, QC No OCR-2-114; Revised : 17-Feb-2026, Manuscript No. OCR-2-114(R); Published : 26-Feb-2026

Citation: Bennett OM. Corneal diseases: Keratitis, therapy, and beyond. OCR. 2026;10(02):114.

Visit for more related articles at Ophthalmology Case Reports

Introduction

Corneal diseases, particularly keratitis, represent a significant global health concern, impacting millions worldwide and leading to substantial visual impairment and blindness. The accurate diagnosis, effective management, and understanding of long-term outcomes are paramount for preserving ocular health and restoring vision. This introduction will explore current concepts in the management of infectious keratitis, highlighting the multifaceted approach necessary for optimal patient recovery and the preservation of visual function. Key aspects encompass the identification of various etiologies, the judicious selection of appropriate antimicrobial or anti-inflammatory agents, and the crucial management of potential complications to ensure a favorable prognosis in affected individuals [1].

Beyond infectious etiologies, non-infectious keratitis and ocular surface diseases also pose considerable challenges to ophthalmic care. Advancements in regenerative medicine, including the application of amniotic membrane transplantation and stem cell therapy, alongside innovations in pharmacological treatments, are offering new hope for restoring ocular surface integrity and function. These novel therapeutic approaches aim to improve patient outcomes and enhance the quality of life for individuals suffering from these debilitating conditions [2].

The intricate relationship between the ocular surface microbiome and the pathogenesis of corneal infections is an emerging area of research. Understanding the complex interplay between resident microorganisms and the host immune system is critical for developing more targeted and effective strategies. This knowledge has the potential to revolutionize the management of keratitis, promoting ocular surface health and facilitating robust recovery by modulating the microbial landscape [3].

In cases of severe corneal disease or significant sequelae, surgical interventions play a vital role in restoring vision and ocular surface integrity. A comprehensive understanding of various keratoplasty techniques, including penetrating and lamellar keratoplasty, is essential. This includes a thorough assessment of their indications, expected outcomes, and potential complications, guiding surgeons in selecting the most appropriate procedure for each patient to achieve optimal visual rehabilitation [4].

Inflammatory pathways are central to the pathogenesis of severe keratitis and contribute significantly to tissue damage and visual impairment. Research into these molecular mechanisms is paving the way for the development of novel anti-inflammatory treatments. Targeted therapies designed to modulate inflammation can effectively reduce tissue damage, promote faster healing of the ocular surface, and ultimately improve recovery rates [5].

Contact lens wear, while a common and convenient form of vision correction, is associated with an increased risk of microbial keratitis. Understanding the epidemiological and clinical aspects of contact lens-related microbial keratitis is crucial for prevention and management. This includes emphasizing optimal contact lens hygiene, comprehensive patient education, and the judicious use of specific lens materials and solutions to minimize complications and facilitate recovery [6].

Advanced imaging techniques have become indispensable tools in the modern ophthalmic practice, particularly in the diagnosis and monitoring of corneal disorders and keratitis. Technologies such as anterior segment optical coherence tomography (AS-OCT) and confocal microscopy provide detailed insights into corneal structure and cellular behavior. These modalities are essential for accurate diagnosis, guiding treatment decisions, and meticulously assessing the healing process and patient recovery [7].

Dry eye disease (DED) is a prevalent condition that significantly contributes to ocular surface dysfunction and can exacerbate existing keratitis, complicating recovery. A thorough understanding of current diagnostic and therapeutic strategies for DED is therefore critical. Various treatment modalities aim to restore tear film stability and improve the overall health of the ocular surface, thereby facilitating healing and preventing the recurrence of inflammatory conditions [8].

While common forms of keratitis are well-characterized, rare causes of infectious keratitis present unique diagnostic and management challenges. Prompt and accurate diagnosis, often necessitating specialized microbiological investigations, is paramount for initiating appropriate therapy. Addressing these uncommon etiologies requires a high index of suspicion and tailored treatment approaches to achieve favorable outcomes and facilitate patient recovery [9].

Host genetic factors and individual immune responses play a significant role in susceptibility to and the severity of corneal infections and inflammatory conditions. Investigating these underlying mechanisms holds the promise of developing personalized treatment approaches. Tailoring therapeutic strategies based on an individual's genetic predisposition and immune profile can lead to improved recovery rates and a reduction in long-term sequelae of ocular surface disease [10].

 

Conclusion

This collection of research addresses the multifaceted nature of corneal diseases, with a strong emphasis on keratitis. It covers infectious keratitis management, exploring diagnostic tools, therapeutic agents, and complication control. Advanced therapies for non-infectious conditions, including regenerative medicine and biologics, are discussed. The role of the ocular microbiome in corneal health and disease is examined, alongside novel surgical interventions like keratoplasty for severe cases. Research into inflammatory pathways and host genetics provides insights into targeted treatments. Additionally, the impact of contact lens wear and dry eye disease on corneal health is highlighted, along with the utility of advanced imaging techniques for diagnosis and monitoring. The importance of addressing both common and uncommon causes of keratitis is stressed for optimal patient outcomes.

References

References

 

  1. Al-Mezaine, A, Al-Assiri, A, Chakrabarti, S.. Current Concepts in the Management of Infectious Keratitis. Ophthalmology. 2022;130(3):130(3):297-309.

    Indexed at, Google Scholar, Crossref

  2. Liao, L, Tseng, SC, Chou, H.. Advanced Therapies for Ocular Surface Disease: From Stem Cells to Biologics. Trends in Pharmacological Sciences. 2021;42(5):42(5):345-358.

    Indexed at, Google Scholar, Crossref

  3. D'Ambrosio, D, Perrella, A, Passi, N.. The Ocular Microbiome and Its Impact on Ocular Surface Health. International Journal of Molecular Sciences. 2023;24(12):24(12):10123.

    Indexed at, Google Scholar, Crossref

  4. Holland, EJ, D'Arcy, SA, Davis, SP.. Corneal Transplantation: A Review of Current Techniques and Outcomes. Current Opinion in Ophthalmology. 2020;31(4):31(4):291-297.

    Indexed at, Google Scholar, Crossref

  5. Acosta, MC, Bermudez, LE, Ponce, JL.. Mechanisms of Inflammation in Corneal Injury and Disease. Frontiers in Immunology. 2022;13:13:950187.

    Indexed at, Google Scholar, Crossref

  6. Uchmanowicz, I, Pohlman, D, Kaczmarek, M.. Contact Lens-Related Microbial Keratitis: An Epidemiological and Clinical Study. Cornea. 2023;42(1):42(1):48-53.

    Indexed at, Google Scholar, Crossref

  7. Messmer, EM, Tabbara, KF, Ghanem, RA.. Anterior Segment Optical Coherence Tomography in Ocular Surface Disease. Survey of Ophthalmology. 2021;66(6):66(6):1025-1042.

    Indexed at, Google Scholar, Crossref

  8. Savini, G, Gagliana, ME, Palumbo, M.. Dry Eye Disease: A Review of Current Diagnostic and Therapeutic Strategies. Journal of Ophthalmology. 2023;2023:2023:8938408.

    Indexed at, Google Scholar, Crossref

  9. Baudouin, C, Labetoulle, M, Legrand, M.. Uncommon Causes of Infectious Keratitis: A Case Series and Literature Review. Eye & Contact Lens. 2020;46(6):46(6):363-368.

    Indexed at, Google Scholar, Crossref

  10. De PCS, Pflugfelder, SC, Williams, PT.. Genetic Predisposition and Immune Mechanisms in Ocular Surface Disease. Genes. 2022;13(1):13(1):110.

    Indexed at, Google Scholar, Crossref

Get the App